ma research semaglutide Losing muscle, as well as fat, is an unexpected downside of the popular weight-loss drugs that isn't broadly discussed or immediately apparent. “We are curing obesity by encouraging frailty.” 📉 ⚖️ 💊 GLP-1 Weight-Loss Drugs Could Address

Rather, it offers the potential to serve as a valuable adjunct therapy, potentially improving both blood sugar control and quality of life

In case of significant gastrointestinal symptoms, consider delaying dose escalation until symptoms have improved

"It didn't suit everyone who took part in the trial as some people got side effects that meant they stopped the drug

Sometimes, taking a complete break from GLP-1 medications is the best approach after a severe reaction

Packer M et al (2020): Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

How long does a 5mg/ml vial last once opened